Nedocromil sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H15NO7.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ET8IF4KS1T, chemically known as 4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt but more generally known as nedocromil sodium, which bears US NIH Compound Identifier 50295. European Medicines Agency schedules Nedocromil sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14634MIG. Most nations, for tariff and trade purposes, schedule nedocromil sodium under HS 29349990 and SITC 51579. As of Q4 2014, NEDOCROMIL SODIUM remains US FDA's Preferred Term for this commodity. Nedocromil sodium bears US NLM identifiers UMLS ID C0886658 and NCI Concept Code C47635. SMILES: CCCC1C2C(CC3C1OC(CC3=O)C(=O)[O-])C(=O)CC(N2CC)C(=O)[O-].[NA+].[NA+].